Stocks to Buy

3 Pharma Stocks to buy in 2019. The pharmaceutical sector delivers two benefits that appeal to investors: reasonable P/E ratios and growth catalysts.

Many pharma stocks have suffered as of late. Some have key drugs facing patent expirations. Meanwhile, others have sold off as trade-related fears or regulatory hurdles both domestically and abroad increase uncertainty. However, some of these companies have responded by developing new drugs. The following 3 pharma stocks appear particularly well-positioned to benefit from new drugs and demographic tailwinds in 2019.